Fatigue after TBI: association with neuroendocrine abnormalities

Area of Science:

• Neuroendocrinology
• Traumatic Brain Injury Research
• Clinical Psychology

Background:

• Fatigue is a common and persistent symptom following traumatic brain injury (TBI).
• The underlying mechanisms of post-TBI fatigue are not fully understood, with neuroendocrine dysfunction being a potential contributor.
• Previous hypotheses suggested growth hormone (GH) deficiency might be linked to fatigue after TBI.

Purpose of the Study:

• To investigate the association between neuroendocrine system abnormalities and fatigue levels in individuals with a history of TBI.
• To explore the relationship between specific pituitary axes (thyroid, adrenal, gonadal, GH) and fatigue severity.

Main Methods:

• A prospective, observational study involving 64 participants at least 1 year post-TBI.
• Neuroendocrine testing included evaluation of thyroid, adrenal, and gonadal axes, plus GH response to glucagon stimulation.
• Fatigue was assessed using the Global Fatigue Index (GFI) and the Fatigue Severity Scale (FSS).

Main Results:

• Participants reported significantly higher fatigue scores (GFI and FSS) compared to control data.
• Abnormalities in at least one pituitary axis were present in 90% of the TBI sample.
• Higher GH levels were significantly associated with increased fatigue severity (higher FSS scores).
• A trend indicated that lower basal cortisol levels were associated with higher fatigue scores (FSS and GFI).

Conclusions:

• The findings contradict the hypothesis that GH deficiency causes fatigue post-TBI, showing instead a positive association between higher GH and fatigue.
• Lower basal cortisol was associated with increased fatigue, aligning with expectations.
• The study recommends screening for hypopituitarism post-TBI due to the high prevalence of pituitary abnormalities.
• The impact of GH deficiency on quality of life after TBI requires further investigation.